Evidence map›Paper›PMID 34288905›Full record

ArticlePLoS neglected tropical diseases2021

"Chagas Express XXI": A new ArtScience social technology for health and science education-A case study in Brazilian endemic areas of Chagas disease with an active search of chronic cases.

Tania C Araujo-Jorge, Roberto R Ferreira, Rita C M Rocha, Thallyta M Vieira, Nancy D Costa, Luzia L Santos, Josefa O Silva, Marcelo O Mendes, Juliana Almeida-Silva, Erik J Costa and 11 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The 50th Anniversary Conference - Caxambu 2024.Memorias do Instituto Oswaldo Cruz · 2025
    Article
  4. Article
  5. High Parasitic Loads Quantified in SylvaticPathogens (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Tania C Araujo-JorgeLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.ORCID 0000-0002-8233-5845
Roberto R FerreiraLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.ORCID 0000-0001-5010-7007
Rita C M RochaLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
Thallyta M VieiraCenter for Biological and Health Science, Universidade Estadual de Montes Claros, Minas Gerais, Brazil.ORCID 0000-0002-1483-6234
Nancy D CostaRio Chagas Association, Rio de Janeiro, Brazil.
Luzia L SantosRio Chagas Association, Rio de Janeiro, Brazil.
Josefa O SilvaRio Chagas Association, Rio de Janeiro, Brazil.
Marcelo O MendesLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
Juliana Almeida-SilvaLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.ORCID 0000-0002-3922-3514
Erik J CostaLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.ORCID 0000-0001-5427-9279
Rodrigo MexasInstitute for Science and Technology Information, (ICICT/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Jonathan G OliveiraLaboratory of Biology and Parasitology of Wild Reservoir Mammals, Oswaldo Cruz Institute (LABPMR-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0001-6973-7068
Ana M Suarez-FontesLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.ORCID 0000-0001-8522-3104
Teresa C M GonçalvesInterdisciplinary Laboratory in Entomological surveillance in Diptera and Hemiptera, Oswaldo Cruz Institute (LIVEDIH-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0001-7472-0391
Catarina M LopesInterdisciplinary Laboratory in Entomological surveillance in Diptera and Hemiptera, Oswaldo Cruz Institute (LIVEDIH-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0001-8018-5110
Marcio L MelloLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.ORCID 0000-0002-5434-8913
Cristina X A BorgesLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.ORCID 0000-0002-1120-9518
Luciana R GarzoniLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
Daniel GibaldiLaboratory of Biology of the Interactions, Oswaldo Cruz Institute (LBI-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0002-9882-0810
Joseli Lannes-VieiraLaboratory of Biology of the Interactions, Oswaldo Cruz Institute (LBI-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0001-5503-6754
Marcos A Vannier-SantosLaboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
Fundação Oswaldo Cruz · BRFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro · BRUniversidade Estadual de Montes Claros · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChagas Disease (CD) affects 6-7 million people worldwide and is related to poverty-promoting conditions. Chronic asymptomatic cases are mostly invisible to health systems. Aiming (1) to translate CD discoveries into education/information practices to raise alertness and empowerment of affected people; and (2) to perform an active search of CD cases, articulating intersectoral actions to improve the access of infected people to the local health service for the treatment of CD; our research group developed and tested under field conditions as innovative social technology: an itinerant education interdisciplinary setting named "Chagas Express XXI" (CE21). METHODOLOGY: CE21 was created as an "imaginary train" with ~40 ArtScience workshops, games, laboratory activities and conversation circles. An entry/exit plus six activity modules combined associations of affected people, microscopic observations, One Health education, and wellness activities. CE21 was conceived as a social technology, since all the processes were co-created with CD patients and inter-sector local partners. Descriptive statistics showed quantitative data collected throughout the expeditions (CD knowledge, serological results). Qualitative data accessed the public perceptions about the education activities. PRINCIPAL

findingsCE21 was exhibited in local educational institutions (schools, universities) in four cities, engaging 2,117 people that evaluated the 41 activities carried out. Citizens and health professionals enjoyed acquisition of information related to blood, parasites, vectors, reservoirs, environmental changes, and social determinants of CD. Further, local legacies of 600 participants volunteer for health promotion groups and CD associations, local empowerment groups to fight for better health conditions, and 05 mural paintings. We observed that 81% of the participants ignored the possibility of treating CD while 52% of the participants requested a blood test for CD showing seropositivity in 20% of them.

conclusionsCE21 is a social technology potentially useful for health and science education and active search of asymptomatic CD chronic cases. Moreover, this technology may be adapted to understand and to cooperate in other potentially epidemic situations, especially NTDs related.

Indexed as

Health EducationAdultAgedBrazilChagas DiseaseFemaleHealth PromotionHumansMaleMiddle AgedScienceTechnologyYoung Adult

Identifiers

PMID34288905
PMCPMC8366985
OpenAlexW3184437827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.